third stage
(2017)
begin to start the generation of leadership alternation, build a research and development platform with technical barriers.
in 2018, qingfeng innovation incubator launched to operation. in 2019, sales reaches 5 billion. organization adjusted for focusing on innovation. in 2020, preparing for ipo.
in 2001, moved to industrial park, the asset was reorganized and expand
in 2005, establishing r&d center and marketing and commercializing system
in 2008, establishing qingfeng pharma group with investment outreach
in 2010, establishing multi r&d platform, and acquire shanghai denovo. sales exceeds 1 billion.
in 2016, sales reaches 4 billion.shanghai r&d headquarter established.
|
|